Drug Profile
Rabies immune globulin purified - Grifols
Alternative Names: RIG-CLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Grifols
- Class Antivirals; Immunoglobulins
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Rabies
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for phase-I development in Rabies(Prevention) in USA (IM, Injection)
- 01 May 2014 Grifols completes a phase I trial in Rabies (Prevention) in USA (NCT02139657)
- 01 Mar 2014 Phase-I clinical trials in Rabies (Prevention) in USA (IM) (NCT02139657)